HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emerging and reemerging microbial threats. Nosocomial fungal infections.

Abstract
The incidence of nosocomial fungal infections had been increasing steadily for the past 25 years. Although they were once believed to be of little clinical consequence, there is now compelling evidence that fungal agents represent a bona fide microbial threat with substantial morbidity and high mortality. Reporting on a series of 30447 nosocomial fungal infections that occurred in the decade from 1980 to 1990, Beck-Sague and Jarvis noted increases in incidence from 90% to 175%. Infection rates rose from 2.0 per 1000 discharges to as high as 6.6 infections per 1000 discharges. Fungal infections increased at all major anatomic sites, including surgical wounds, lung, urinary tract, and bloodstream. Candida species accounted for 78.3% of nosocomial fungal infections, while torulopsis species and aspergillus species accounted for 7.3% and 1.3%, respectively.
AuthorsV J Henderson, E R Hirvela
JournalArchives of surgery (Chicago, Ill. : 1960) (Arch Surg) Vol. 131 Issue 3 Pg. 330-7 (Mar 1996) ISSN: 0004-0010 [Print] United States
PMID8611100 (Publication Type: Journal Article, Review)
Topics
  • Cross Infection (diagnosis, microbiology, mortality, therapy)
  • Humans
  • Mycoses (diagnosis, microbiology, mortality, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: